Granted Patent B2

US 12,544,577 · App. 17/856,046 · Granted Feb 10, 2026

Inventor: Xiaohong Zhou (Woodbury, MN)

Assignee: Medtronic, Inc.

A61N1/365A61N1/056

Abstract

Claims (57)

1 . A method for determining, by a medical device coupled to a plurality of leads including a first lead, the first lead comprising a left-ventricular lead, and configured to deliver left-ventricular pacing via the left-ventricular lead, whether electrical stimulation provided conduction system pacing, the method comprising:

sensing, by the medical device, two or more left-ventricular activations via two or more electrodes of a plurality of electrodes of the left-ventricular lead, wherein each of the two or more left-ventricular activations are in response to delivery of an electrical stimulation to a heart of a patient by a second lead of the plurality of leads different from the left-ventricular lead;

determining, by the medical device, one or more left-ventricular activation metrics based on the sensed two or more left-ventricular activations, wherein determining the one or more left-ventricular activation metrics comprises comparing the two or more left-ventricular activations to each other;

determining, by the medical device, that the electrical stimulation did not provide conduction system pacing (CSP) based on the one or more ventricular activation metrics; and

in response to determining that the electrical stimulation did not provide CSP, delivering subsequent electrical stimulation having at least one of an increased pulse amplitude or an increased pulse width based on the determination that the electrical stimulation did not provide conduction system pacing.

2 . The method of claim 1 , wherein determining the one or more left-ventricular activation metrics comprises comparing an interval between the delivery of the electrical stimulation and the sensing of each left-ventricular activation of the two or more left-ventricular activations.

3 . The method of claim 2 , wherein sensing each left-ventricular activation comprises sensing one of the two or more left-ventricular activations via a distal-most electrode of the plurality of electrodes of the left-ventricular lead.

4 . The method of claim 1 , wherein comparing the two or more left-ventricular activations comprises determining one or more respective intervals between the two or more left-ventricular activations.

5 . The method of claim 1 , wherein the two of the two or more electrodes comprise a proximal-most electrode and a distal-most electrode of the plurality of electrodes of the left-ventricular lead.

6 . The method of claim 1 , wherein determining the one or more left-ventricular activation metrics comprises determining a morphology of at least one left-ventricular activation of the two or more left-ventricular activations.

7 . The method of claim 6 , wherein the two or more electrodes comprise a proximal-most electrode and a distal-most electrode of the plurality of electrodes of the left-ventricular lead.

8 . The method of claim 1 , wherein the electrical stimulation comprises a first electrical stimulation delivered via a CSP electrode on the second lead of the plurality of leads, wherein the second lead is configured so that the CSP electrode may be positioned in the intraventricular septum or the atrioventricular septum,

wherein sensing the two or more left-ventricular activations comprises:

sensing a first activation via the plurality of electrodes of the left-ventricular lead in response to delivery of the first electrical stimulation; and

sensing a second activation via the CSP electrode in response to delivery of a second electrical stimulation via the one or more electrodes of the plurality of electrodes of the left-ventricular lead,

wherein comparing the two or more left-ventricular activations comprises:

determining a first activation interval of the first activation;

determining a second activation interval of the second activation; and

comparing the first activation interval to the second activation interval.

9 . The method of claim 8 , wherein sensing the first activation and delivering the second electrical stimulation comprises sensing the first activation and delivering the second electrical stimulation via a distal-most electrode of the left-ventricular lead.

10 . The method of claim 1 , wherein determining the electrical stimulation did not provide CSP comprises determining the electrical stimulation did not provide left bundle branch pacing.

11 . The method of claim 1 , wherein determining the electrical stimulation did not provide conduction system pacing comprises determining the electrical stimulation did not provide conduction system or myocardial pacing.

12 . The method of claim 1 , further comprising, in response to determining the electrical stimulation did not provide conduction system pacing, adjusting a position of an electrode used to deliver the electrical stimulation based on the determination that the electrical stimulation did not provide CSP.

13 . A system comprising:

a plurality of leads comprising a first lead, the first lead comprising a left-ventricular lead, and a second lead, the second lead being different from the left-ventricular lead;

an implantable medical device coupled to the plurality of leads and configured to deliver left-ventricular pacing via the left-ventricular lead, the implantable medical device comprising:

sensing circuitry,

therapy delivery circuitry, and

processing circuitry configured to:

sense, using the sensing circuitry, two or more left-ventricular activations via two or more electrodes of the left-ventricular lead, wherein each of the two or more left-ventricular activations are in response to delivery of an electrical stimulation to a heart of a patient by the second lead of the plurality of leads;

determine one or more left-ventricular activation metrics based on the sensed one or more left-ventricular activations, wherein to determine the one or more left-ventricular activation metrics, the processing circuitry is configured to compare the two or more left-ventricular activations to each other;

determine the electrical stimulation provided conduction system pacing (CSP) based on the one or more ventricular activation metrics; and

in response to determining the electrical stimulation provided CSP, control the therapy delivery circuitry to deliver subsequent electrical stimulation via a CSP electrode on the second lead of the plurality of leads, wherein the CSP electrode is configured to be positioned in the intraventricular septum or the atrioventricular septum.

14 . The system of claim 13 , wherein the implantable medical device comprises an implantable pacemaker configured to be coupled to the left-ventricular lead and the second lead of the plurality of leads, the implantable pacemaker comprising the sensing circuitry and the processing circuitry, and further comprising therapy delivery circuitry configured to deliver the electrical stimulation via the second lead.

15 . The system of claim 13 , wherein the implantable medical device comprises an implantable pacemaker configured to be coupled to the plurality of leads, the implantable pacemaker comprising the sensing circuitry, the therapy delivery circuitry, and the processing circuitry.

16 . An implantable medical device comprising:

a means for sensing two or more left-ventricular activations via two or more electrodes of a first lead comprising a left-ventricular lead positioned within a coronary sinus, wherein each of the two or more left-ventricular activations are in response to delivery of an electrical stimulation to a heart of a patient by a second lead of a plurality of leads, the second lead being different from the left-ventricular lead;

a means for determining one or more left-ventricular activation metrics based on the sensed two or more left-ventricular activations, wherein determining the one or more left-ventricular activation metrics comprises comparing the two or more left-ventricular activations;

a means for determining the electrical stimulation did not provide conduction system pacing (CSP) based on the one or more ventricular activation metrics; and

a means for, in response to determining the electrical stimulation did not provide CSP, delivering subsequent electrical stimulation having at least one of an increased pulse amplitude or an increased pulse width based on the determination that the electrical stimulation did not provide conduction system pacing.

17 . A method for determining, by a medical device coupled to a plurality of leads including a first lead, the first lead comprising a left-ventricular lead, and configured to deliver left-ventricular pacing via the left-ventricular lead, whether electrical stimulation provided conduction system pacing, the method comprising:

sensing, by the medical device, two or more left-ventricular activations via two or more electrodes of a plurality of electrodes of the left-ventricular lead, wherein each of the two or more left-ventricular activations are in response to delivery of an electrical stimulation to a heart of a patient by a second lead of the plurality of leads different from the left-ventricular lead;

determining, by the medical device, one or more left-ventricular activation metrics based on the sensed two or more left-ventricular activations, wherein determining the one or more left-ventricular activation metrics comprises comparing the two or more left-ventricular activations to each other;

determining, by the medical device, that the electrical stimulation did not provide conduction system pacing (CSP) based on the one or more ventricular activation metrics; and

in response to determining that the electrical stimulation did not provide CSP, delivering subsequent electrical stimulation via the left-ventricular lead based on the determination that the electrical stimulation did not provide conduction system pacing.

18 . The method of claim 17 , wherein determining the one or more left-ventricular activation metrics comprises comparing an interval between the delivery of the electrical stimulation and the sensing of each left-ventricular activation of the two or more left-ventricular activations.

19 . The method of claim 18 , wherein sensing each left-ventricular activation comprises sensing one of the two or more left-ventricular activations via a distal-most electrode of the plurality of electrodes of the left-ventricular lead.

20 . A system comprising:

a plurality of leads comprising a first lead, the first lead comprising a left-ventricular lead, and a second lead, the second lead being different from the left-ventricular lead;

an implantable medical device coupled to the plurality of leads and configured to deliver left-ventricular pacing via the left-ventricular lead, the implantable medical device comprising:

sensing circuitry,

therapy delivery circuitry, and

processing circuitry configured to:

sense, using the sensing circuitry, two or more left-ventricular activations via two or more electrodes of the left-ventricular lead, wherein each of the two or more left-ventricular activations are in response to delivery of an electrical stimulation to a heart of a patient by the second lead of the plurality of leads;

determine one or more left-ventricular activation metrics based on the sensed one or more left-ventricular activations, wherein to determine the one or more left-ventricular activation metrics, the processing circuitry is configured to compare the two or more left-ventricular activations to each other;

determine the electrical stimulation did not provide conduction system pacing (CSP) based on the one or more ventricular activation metrics; and

in response to determining the electrical stimulation did not provide CSP, control the therapy delivery circuitry to deliver subsequent electrical stimulation via the left-ventricular lead.

Assignments (1)

Continuity (2)

References Cited (18)